Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
Colle + McVoy looks to steal some of the market share it built for a competitor with its first work for Novartis’ animal-health division.
The Minneapolis shop today breaks a TV commercial for Deramaxx, a dog arthritis treatment. The prescription drug is Novartis’ answer to Pfizer’s Rimadyl, which was launched in 1998 with ads from Colle + McVoy. The shop dropped its Pfizer animal-health account in November to take on Novartis, for reasons that included greater growth potential.
The spot, running on network and cable, shows an aging dog struggling to descend stairs or jump into a car.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in